Haisco Pharmaceutical Group Co., Ltd.
002653
株式のランク
#2029
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
株価
$8.83
時価総額
$10.08B
変化（1日）
-2.17%
変化（1年）
21.06%
国
CN
取引 Haisco Pharmaceutical Group Co., Ltd. (002653)
カテゴリー
Healthcare
Haisco Pharmaceutical Group Co., Ltd.（002653）の株価履歴
終値の最高値: $8.59 （2026-10-01）
終値の最安値: $0.93 （2012-01-01）
終値の最安値: $0.93 （2012-01-01）
Haisco Pharmaceutical Group Co., Ltd. の株価履歴（2012 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | 4.52% |
| 2025 | 62.09% |
| 2024 | 53.40% |
| 2023 | 3.49% |
| 2022 | -3.43% |
| 2021 | 6.93% |
| 2020 | 1.93% |
| 2019 | 72.56% |
| 2018 | -3.89% |
| 2017 | -27.17% |
| 2016 | -30.04% |
| 2015 | 15.52% |
| 2014 | -9.68% |
| 2013 | 123.22% |
| 2012 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
